SUPREM: an engineered non-site-specific m6A RNA methyltransferase with highly improved efficiency
Nucleic Acids Research · 2024
DOI: 10.1093/nar/gkae887 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2024. Verfasst von Yoshiki Ochiai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Protein Engineering and Evolution Unit, Okinawa Institute of Science and Technology Graduate University (OIST), 1919-1 Tancha, Onna, Kunigami Distric…. Hauptthemen laut MEDLINE: Protein Engineering, Adenine. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Okinawa Institute of Science and Technology, The Japan Science Society, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
N 6-Methyladenine (m6A) RNA methylation plays a key role in RNA processing and translational regulation, influencing both normal physiological and pathological processes. Yet, current techniques for studying RNA methylation struggle to isolate the effects of individual m6A modifications. Engineering of RNA methyltransferases (RNA MTases) could enable development of improved synthetic biology tools to manipulate RNA methylation, but it is challenging due to limited understanding of structure–function relationships in RNA MTases. Herein, using ancestral sequence reconstruction, we explore the sequence space of the bacterial DNA methyltransferase EcoGII (M.EcoGII), a promising target for protein engineering due to its lack of sequence specificity and its residual activity on RNA. We thereby created an efficient non-specific RNA MTase termed SUPer RNA EcoGII Methyltransferase (SUPREM), which exhibits 8-fold higher expression levels, 7°C higher thermostability and 12-fold greater m6A RNA methylation activity compared with M.EcoGII. Immunofluorescent staining and quantitative liquid chromatography-tandem mass spectrometry (LC–MS/MS) analysis confirmed SUPREM’s higher RNA methylation activity compared with M.EcoGII in mammalian cells. Additionally, Nanopore direct RNA sequencing highlighted that SUPREM is capable of methylating a larger number of RNA methylation sites than M.EcoGII. Through phylogenetic and mutational analysis, we identified a critical residue for the enhanced RNA methylation activity of SUPREM. Collectively, our findings indicate that SUPREM holds promise as a versatile tool for in vivo RNA methylation and labeling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Protein Engineering and Evolution Unit, Okinawa Institute of Science and Technology Graduate University (OIST), 1919-1 Tancha, Onna, Kunigami District, Okinawa 904-0495, Japan.
- Molecular Neuroscience Unit, Okinawa Institute of Science and Technology Graduate University (OIST), 1919-1 Tancha, Onna, Kunigami District, Okinawa 904-0495, Japan.
- Institute for Protein Research, Osaka University, 3-2 Yamadaoka, Suita-shi, Osaka 565-0871, Japan.
ORCID-Profile: Paola Laurino
Förderung
- Okinawa Institute of Science and Technology
- The Japan Science Society
- Japan Society for the Promotion of Science
Zitieren
APA
Ochiai, Y., Clifton, B. E., Le Coz, M., Terenzio, M., & Laurino, P. (2024). SUPREM: an engineered non-site-specific m6A RNA methyltransferase with highly improved efficiency. Nucleic Acids Research. https://doi.org/10.1093/nar/gkae887
Vancouver
Ochiai Y, Clifton BE, Le Coz M, Terenzio M, Laurino P. SUPREM: an engineered non-site-specific m6A RNA methyltransferase with highly improved efficiency. Nucleic Acids Research. 2024. doi:10.1093/nar/gkae887
BibTeX
@article{Ochiai2024,
author = {Ochiai, Yoshiki and Clifton, Ben E and Le Coz, Madeleine and Terenzio, Marco and Laurino, Paola},
title = {SUPREM: an engineered non-site-specific m6A RNA methyltransferase with highly improved efficiency},
journal = {Nucleic Acids Research},
year = {2024},
doi = {10.1093/nar/gkae887}
}
EUVIMED